Upregulation of c-fos in activated T lymphoid and monocytic cells by human immunodeficiency virus-1 Tat protein

Blood

Volumn 89, Issue 5, 1997, Pages 1654-1664

  Gibellini, Davide ^b   Caputo, Antonella ^b   Capitani, Silvano ^b   La Placa, Michele ^b   Zauli, Giorgio ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DELETION MUTANT; GENE DELETION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERMINAL REPEAT; LYMPHOID TISSUE; MONOCYTE; ONCOGENE C FOS; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR UPREGULATION; T LYMPHOCYTE ACTIVATION; TRANSACTIVATION; TRANSCRIPTION REGULATION; VIRUS GENE; VIRUS REPLICATION;

EID: 0031020168     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.5.1654     Document Type: Article

References (63)

1. Jones KA, Peterlin MB: Control of RNA initiation and elongation at the HIV-1 promoter. Annu Rev Biochem 63:717, 1994
2. Koken SEC, Greijer AE, Verhoef K, van Wamel J, Bukrinskaya AG, Berkout B: Intracellular analysis of in vitro modified HIV Tat protein. J Biol Chem 269:8366, 1994
3. Dang CV, Lee WMF: Nuclear and nucleolar targeting sequences of c-erb-A, c-myc, N-myc, p53, HPS70, and HIV tat prqteins. J Biol Chem 264:18019, 1989
4. Dingwall C, Ernberg I, Gait MJ, Green SM, Heaphy S, Karn J, Lowe AD, Singh M, Skinner MA, Valerio R: HIV-1 tat protein binds transactivation-response region (TAR) in vitro. Proc Natl Acad Sci USA 86:6925, 1989
5. Cullen BR: Regulation of HIV-1 gene expression. FASEB J 5:2361, 1991
6. Taylor JP, Kundu M, Khalili K: TAR-independent activation of HIV-1 requires the activation domain but not the RNA-binding domain of Tat. Virology 195:780, 1993
7. Huang L, Joshi A, Willey R, Orenstein J, Jeang KT: Human immunodeficiency viruses regulated by alternative trans-activators: Genetic evidence for a novel non-transcriptional function of Tat in virion infectivity. EMBO J 13:2886, 1994
8. Albini A, Fontanini G, Masiello L, Tacchetti C, Bigini D, Luzzi P, Noonan DM, Stetler-Stevenson WG: Angiogenic potential in vivo by Kaposi's sarcoma cell-free supernatants and HIV-1 tat product: Inhibition of KS-like lesions by tissue inhibitor of metallo-proteinase-2. AIDS 8:1237, 1994
9. Ensoli B, Barillari G, Zaki Salahuddin S, Gallo RC, Wong-Stall F: Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 345:84, 1990
10. Zauli G, Gibellini D, Milani D, Mazzoni M, Borgatti P, La Placa M, Capitani S: Human immunodeficiency virus type 1 Tat protein protects lymphoid, epithelial, and neuronal cell lines from death by apoptosis. Cancer Res 53:4481, 1993
11. Viscidi RP, Mayur K, Lederman HM, Frankel AD: Inhibition of antigen-induced lymphocyte proliferation by tat protein from HIV-1. Science 246:1606, 1989
12. Subramanyam M, Gutheil WG, Bachovchin WW, Huber BT: Mechanism of HIV-1 Tat induced inhibition of antigen-specific T cell responsiveness. J Immunol 150:2544, 1993
13. Chirmule N, Than S, Khan S, Pahwa S: Human immunodeficiency virus Tat induces functional unresponsiveness in T cells. J Virol 69:492, 1995
14. Li CJ, Friedman DJ, Wang C, Metelev V, Pardee AB: Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 268:229, 1995a
15. Westendorp MO, Frank R, Ochsenbauer C, Stricker K, Dhein J, Walezak H, Debatin KM, Krammer PH: Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375:497, 1995
16. Purvis SF, Jacobberger JW, Sramkoski RM, Patki AH, Lederman MM: HIV type 1 Tat protein induces apoptosis and death in Jurkat cells. AIDS Res Hum Retroviruses 11:443, 1995
17. Vellutini C, Horschowski N, Philippon V, Gambarelli D, Nave KA, Filippi P: Development of lymphoid hyperplasia in transgenic mice expressing the HIV tat gene. AIDS Res Hum Retroviruses 11:21, 1995
18. Mace K, Gazzolo L: Expression of the Tat protein of HIV1 in human promonocytic U937 cells. Res Virol 144:27, 1993
19. Flores SC, Marecki JC, Harper KP, Bose SK, Nelson SK, McCord JM: Tat protein of HIV-1 represses expression of manganese Superoxide dismutase in HeLa cells. Proc Natl Acad Sci USA 90:7632, 1993
20. Longo F, Marchetti MA, Castagnoli L, Battaglia PA, Gigliani F: A novel approach to protein-protein interaction: Complex formation between p53 tumor suppressor and the HIV Tat proteins. Biochem Biophys Res Commun 206:326, 1995
21. Li CJ, Wang C, Friedman DJ, Pardee AB: Reciprocal modulations between p53 and Tat of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 92:5461, 1995b
22. Westendorp MO, Shatrov VA, Schulze-Osthoff K, Frank R, Kraft M, Los M, Krammer PH, Droge W, Lehmann V: HIV-1 Tat potentiates TNF-induced NF-κβ activation and cytotoxicity by altering the cellular redox state. EMBO J 14:546, 1995
23. Zauli G, Davis BR, Re MC, Visani G, Furlini G, La Placa M: Tat protein stimulates production of transforming growth factorβ1 by marrow macrophages: A potential mechanism for HIV-1 induced hematopoietic suppression. Blood 80:3036, 1992
24. Buonaguro L, Barillari G, Chang HK, Bohan CA, Kao V, Morgan R, Gallo RC, Ensoli B: Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokine. J Virol 66:7159, 1992
25. Purvis SF, Georges DL, Williams TM, Lederman MM: Suppression of interleukin-2 and interleukin-2 receptor expression in Jurkat cells stably expressing the human immunodeficiency virus Tat protein. Cell Immunol 144:32, 1992
26. Scala G, Ruocco MR, Ambrosino C, Mallardo M, Giordano V, Baldassarre F, Dragonetti E, Quinto I, Venuta S: The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 tat protein. J Exp Med 179:961, 1994
27. Gibellini D, Zauli G, Re MC, Milani D, Furlini G, Caramelli E, Capitani S, La Placa M: Recombinant human immunodeficiency virus type-1 (HIV-1) Tat protein sequentially upregulates IL-6 and TGF-β1 mRNA expression and protein synthesis in peripheral blood monocytes. Br J Haematol 88:261, 1988
28. Westendorp MO, Li-Weber M, Frank RW, Krammer PH: Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells. J Virol 68:4177, 1994
29. Zauli G, Gibellini D, Caputo A, Bassini A, Negrini M, Monne M, Mazzoni M, Capitani S: The human immunodeficiency virus type-1 (HIV-1) Tat protein upregulates Bcl-2 gene expression in Jurkat T cell lines and primary peripheral blood mononuclear cells. Blood 86:3823, 1995
30. Ensoli B, Buonaguro L, Barillari G, Fiorelli V, Gendelman R, Morgan RA, Wingfield P, Gallo RC: Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol 67:277, 1993
31. Frankel AD, Pabo CO: Cellular uptake of the Tat protein from human immunodeficiency virus. Cell 55:1189, 1988
32. Mann DA, Frankel AD: Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO J 10:1733, 1991
33. Fawell S, Seery J, Daikh Y, Moore C, Chen LL, Pepinsky B, Barsoum J: Tat-mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci USA 91:664, 1994
34. Helland DE, Welles JL, Caputo A, Haseltine WA: Transcellular transactivation by the human immunodeficiency virus type 1 tat protein. J Virol 65:4547, 1991
35. Marcuzzi A, Weinberger J, Weinberger OK: Transcellular activation of the human immunodeficiency virus type 1 long terminal repeat in cocultured lymphocytes. J Virol 66:4228, 1992
36. Thomas CA, Dobkin J, Weinberger OK: Tat-mediated transcellular activation of HIV-1 long terminal repeat directed gene expression by HIV-1-infected peripheral blood mononuclear cells. J Immunol: 153:3831, 1994
37. Zauli G, La Placa M, Vignoli M, Re MC, Gibellini D, Furlini G, Milani D, Marchisio M, Mazzoni M, Capitani S: An autocrine loop of HIV type 1 Tat protein responsible for the improved survival/proliferation capacity of permanently tat-transfected cells and required for optimal human immunodeficiency virus type 1 long terminal repeat transactivating activity. J AIDS 10:306, 1995
38. Steinaa L, Serensen AM, Nielsen JO, Hansen JES: Antibody to HIV-1 Tat protein inhibits the replication of virus in culture. Arch Virol 139:263, 1994
39. Re MC, Furlini G, Vignoli M, Ramazzotti E, Roderigo G, De Rosa V, Zauli G, Lolli S, Capitani S, La Placa M: Effect of antibody to HIV-1 Tat protein on viral replication in vitro and progression of HIV-1 disease in vivo. J AIDS 10:408, 1995
40. Fauci AS: Multifactorial nature of human immunodeficiency virus disease: Implications for therapy. Science 262:1011, 1993
41. Deschamps J, Meijlink F, Verma IM: Identification of a transcriptional enhancer element uptream from the proto-oncogene fos. Science 230:1174, 1985
42. Van Straaten F, Muller R, Curran T, van Beveren C, Verma IM: Complete nucleotide sequence of human c-onc gene: Deduced aminoacid sequence of the human c-fos protein. Proc Natl Acad Sci USA 80:3183, 1983
43. Fujii M, Sassone-Corsi P, Verma IM: c-fos promoter transactivation by the tax 1 protein of human T-cell leukemia virus type 1. Proc Natl Acad Sci USA 85:8526, 1988
44. Gibellini D, Caputo A, Celeghini C, Bassini A, La Placa M, Capitani S, Zauli G: Tat-expressing Jurkat cells show an increased resistance to different apoptotic stimuli, including acute human immunodeficiency virus-type 1 (HIV-1) infection. Br J Haematol 89:24, 1995
45. Sassone-Corsi P, Lamph WW, Verma IM: Regulation of proto-oncogene fos: A paradigm for early response genes. Cold Spring Harbor Symp Quant Biol 53:749, 1988
46. Kastan MB, Stone KD, Civin CI: Nuclear oncoprotein expression as a function of lineage, differentiation stage, and proliferative status of normal human hematopoietic cells. Blood 74:1517, 1989
47. Kerr LD, Holt JT, Matrisian LM: Growth factors regulate transin gene expression by c-fos-dependent and c-fos-independent pathways. Science 242:1424, 1988
48. Tremble P, Damsky CH, Werb Z: Components of the nuclear signaling cascade that regulate collagenase gene expression in response to integrin-derived signals. J Cell Biol 129:1707, 1995
49. Angel P, Imagawa M, Chiu R, Stein B, Imbra R, Rahmsdorf J, Jonat C, Herrlich P, Karin M: Phorbol ester-inducible genes contain a common cis-element recognized by a TPA-modulated trans-acting factor. Cell 49:729, 1987
50. Franza BR, Rauscher FJ, Josephs SF, Curran T: The fos complex and fos related antigens recognize sequence elements that contain AP1 binding sites. Science 239:1150, 1989
51. Smeal T, Angel P, Meek J, Karin M: Different requirements for the formatin of Jun:Jun and Jun:Fos complexes. Genes Dev 3:2091, 1989
52. Stein B, Baldwin AS, Ballard DW, Greene WC, Angel P, Herrlich P: Cross-coupling of the NF-κβ p65 and Fos/Jun transcription factors produces potential biological function. EMBO J 12:3879, 1993
53. Hai T, Curran T: Cross-family dimerization of transcription factors Fos/jun and ATF/CREB alters DNA binding specificity. Proc Natl Acad Sci USA 88:3720, 1991
54. Buonaguro L, Buonaguro FM, Giraldo G, Ensoli B: The human immunodeficiency virus type 1 Tat protein transactivates tumor necrosis factor beta gene expression through a TAR-like structure. J Virol 68:2677, 1994
55. Chowdhury M, Taylor JP, Chang CF, Rappaport J, Khalili K: Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat. J Virol 66:7355, 1992
56. Brake DA, Debouck C, Biesecher G: Identification of an Arg-Gly-Asp (RGD) cell adhesion site in human immunodeficiency virus type 1 transactivation protein, Tat. J Cell Biol 111:1275,1990
57. Vogel BE, Lee SJ, Hildebrand A, Craig W, Pierschbacher MD, Wong-Staal F, Ruoslahti E: A novel integrin specificify exemplified by binding of the αvβ5 integrin to the basic domain of the HIV tat protein and vitronectin. J Cell Biol 121:461, 1993
58. Weeks BS, Desai K, Loewenstein PM, Klotman ME, Klotman P, Green M, Kleinman HK: Identification of a novel cell attachment domain in the HIV-1 Tat protein and its 90-kDa cell surface binding protein. J Biol Chem 268:5279, 1993
59. Barillari G, Gendelman R, Gallo RC, Ensoli B: The tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same types by using integrin receptors recognizing RGD amino acid sequence. Proc Natl Acad Sci USA 90:7941, 1993
60. Yamada A, Nikaido T, Nojima Y, Schlossman SF, Marimoto C: Activation of Human CD4 T lymphocytes. Interaction of fibronectin with VLA-5 receptor on CD4 cells induces the AP-1 transcription factor. J Immunol 146:53, 1991
61. Tay DLM, Hoffbrand AV, Wickremasinghe RG: Expression of c-fos and c-jun proteins and AP-1 binding activity during cell cycle progression of HL60 cells and phytohemagglutinin-stimulated lymphocytes. Exp Hematol 24:277, 1996
62. Nabel G, Baltimore D: An inducible transcription factor activates expression of human immmunodeficiency virus in T-cell. Nature 326:711, 1987
63. Roebuck KA, Brenner DA, Kagnoff MF: Identification of c-fos-responsive elements downstream of TAR in the long terminal repeat of human immunodeficiency virus type-1. J Clin Invest 92:1336, 1993